In Brief: GSK Sales Drop; FTC Bans Firm From U.S. Market; FDA Warning Letters
This article was originally published in The Tan Sheet
Executive Summary
GSK consumer sales drop 4%; Canadian firm banned from weight loss market; basic labeling failures triggers FDA warning letter; claims make Puna Noni products drugs; FDA finds another tainted supplement; and study shows Herbalife is not pyramid scheme.